FDA approves Kebilidi for aromatic L-amino acid decarboxylase deficiency
The U.S. Food and Drug Administration has approved PTC Therapeutics' Kebilidi (eladocagene exuparvovec-tneq) for the ...
Nature2d
In search of a vaccine for leishmaniasis
Researchers hope that immunisation will provide much needed protection against the neglected parasitic disease in conflict ...
Science Daily6d
Cooking up a breakthrough: Engineers refine lipid nanoparticles for better mRNA therapies
Engineers have cooked up a new way to improve mRNA delivery, developing an optimal 'recipe' for ionizable lipids -- key ingredients in lipid nanoparticles (LNPs), the molecules behind the COVID-19 ...